JP2008525397A5 - - Google Patents

Download PDF

Info

Publication number
JP2008525397A5
JP2008525397A5 JP2007547621A JP2007547621A JP2008525397A5 JP 2008525397 A5 JP2008525397 A5 JP 2008525397A5 JP 2007547621 A JP2007547621 A JP 2007547621A JP 2007547621 A JP2007547621 A JP 2007547621A JP 2008525397 A5 JP2008525397 A5 JP 2008525397A5
Authority
JP
Japan
Prior art keywords
piperazine
dichlorophenyl
carboxamide
induced
rhinitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007547621A
Other languages
English (en)
Japanese (ja)
Other versions
JP5118975B2 (ja
JP2008525397A (ja
Filing date
Publication date
Priority claimed from GB0428327A external-priority patent/GB0428327D0/en
Priority claimed from GB0520325A external-priority patent/GB0520325D0/en
Application filed filed Critical
Priority claimed from PCT/GB2005/004895 external-priority patent/WO2006067401A1/en
Publication of JP2008525397A publication Critical patent/JP2008525397A/ja
Publication of JP2008525397A5 publication Critical patent/JP2008525397A5/ja
Application granted granted Critical
Publication of JP5118975B2 publication Critical patent/JP5118975B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007547621A 2004-12-24 2005-12-19 Ccr2bアンタゴニストとしてのヘテロ環式化合物 Expired - Fee Related JP5118975B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0428327.1 2004-12-24
GB0428327A GB0428327D0 (en) 2004-12-24 2004-12-24 Method
GB0520325A GB0520325D0 (en) 2005-10-06 2005-10-06 Method
GB0520325.2 2005-10-06
PCT/GB2005/004895 WO2006067401A1 (en) 2004-12-24 2005-12-19 Heterocyclic compounds as ccr2b antagonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012176224A Division JP2012214507A (ja) 2004-12-24 2012-08-08 Ccr2bアンタゴニストとしてのヘテロ環式化合物

Publications (3)

Publication Number Publication Date
JP2008525397A JP2008525397A (ja) 2008-07-17
JP2008525397A5 true JP2008525397A5 (cg-RX-API-DMAC7.html) 2009-02-19
JP5118975B2 JP5118975B2 (ja) 2013-01-16

Family

ID=36084353

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007547621A Expired - Fee Related JP5118975B2 (ja) 2004-12-24 2005-12-19 Ccr2bアンタゴニストとしてのヘテロ環式化合物
JP2012176224A Pending JP2012214507A (ja) 2004-12-24 2012-08-08 Ccr2bアンタゴニストとしてのヘテロ環式化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012176224A Pending JP2012214507A (ja) 2004-12-24 2012-08-08 Ccr2bアンタゴニストとしてのヘテロ環式化合物

Country Status (17)

Country Link
US (4) US7906645B2 (cg-RX-API-DMAC7.html)
EP (1) EP1831164A1 (cg-RX-API-DMAC7.html)
JP (2) JP5118975B2 (cg-RX-API-DMAC7.html)
KR (1) KR20070091677A (cg-RX-API-DMAC7.html)
AR (1) AR053109A1 (cg-RX-API-DMAC7.html)
AU (2) AU2005317928B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0519288A2 (cg-RX-API-DMAC7.html)
CA (1) CA2589748C (cg-RX-API-DMAC7.html)
IL (1) IL183665A (cg-RX-API-DMAC7.html)
MX (1) MX2007007428A (cg-RX-API-DMAC7.html)
MY (1) MY147400A (cg-RX-API-DMAC7.html)
NO (1) NO20073729L (cg-RX-API-DMAC7.html)
NZ (1) NZ555770A (cg-RX-API-DMAC7.html)
RU (1) RU2423349C2 (cg-RX-API-DMAC7.html)
TW (1) TW200633979A (cg-RX-API-DMAC7.html)
UY (1) UY29312A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006067401A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2872813B1 (fr) 2004-07-09 2007-01-19 Sanofi Synthelabo Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique
JPWO2006028161A1 (ja) * 2004-09-09 2008-05-08 財団法人乙卯研究所 セロトニン5−ht3受容体作動薬
FR2876692B1 (fr) 2004-10-19 2007-02-23 Sanofi Aventis Sa Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
CA2589748C (en) * 2004-12-24 2013-08-13 Astrazeneca Ab Heterocyclic compounds as ccr2b antagonists
KR101336106B1 (ko) 2005-09-16 2013-12-05 얀센 파마슈티카 엔.브이. 히스타민 h3 수용체의 조절제로서 사이클로프로필 아민
GB0525957D0 (en) * 2005-12-21 2006-02-01 Astrazeneca Ab Methods
WO2007079003A2 (en) * 2005-12-29 2007-07-12 Bayer Schering Pharma Aktiengesellschaft Amide inhibitors of leukotriene a4 hydrolase
FR2895989B1 (fr) * 2006-01-06 2010-04-30 Sanofi Aventis Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique
WO2008013622A2 (en) * 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
US9090604B2 (en) 2006-07-27 2015-07-28 E I Du Pont De Nemours And Company Fungicidal azocyclic amides
JPWO2008023720A1 (ja) * 2006-08-23 2010-01-14 アステラス製薬株式会社 ウレア化合物又はその塩
GEP20125425B (en) 2006-10-18 2012-03-26 Pfizer Prod Inc Biaryl ether urea compounds
MX2009005252A (es) 2006-11-17 2009-05-28 Abbott Lab Aminopirrolidinas como antagonistas del receptor de quimiocina.
ES2620818T3 (es) 2006-12-14 2017-06-29 Janssen Pharmaceutica N.V. Procedimiento para la preparación de derivados de piperazinil y diazepanil benzamida
CA2687931C (en) * 2007-05-31 2016-05-24 Boehringer Ingelheim International Gmbh Ccr2 receptor antagonists and uses thereof
JP5368556B2 (ja) * 2008-07-16 2013-12-18 エフ.ホフマン−ラ ロシュ アーゲー 心臓血管疾患の処置のための新規ヘテロシクリル化合物
US20100152197A1 (en) * 2008-12-15 2010-06-17 Astrazeneca Ab (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
WO2011114148A1 (en) 2010-03-17 2011-09-22 Astrazeneca Ab 4h- [1, 2, 4] triazolo [5, 1 -b] pyrimidin-7 -one derivatives as ccr2b receptor antagonists
NZ618795A (en) 2011-05-13 2015-07-31 Array Biopharma Inc Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
JP7254246B2 (ja) 2019-11-25 2023-04-07 アムジエン・インコーポレーテツド デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
WO2024167423A1 (en) 2023-02-07 2024-08-15 Captor Therapeutics S.A. Gspt1 degrader compounds

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133061A (en) * 1962-11-13 1964-05-12 Sterling Drug Inc Piperidine carboxamides and derivatives thereof
US3541085A (en) * 1969-05-09 1970-11-17 American Cyanamid Co Method of preparing thiotricyclic compounds
JPS5331669A (en) 1976-09-06 1978-03-25 Kissei Pharmaceut Co Ltd Novel n-acylpiperidinecaroxyanilide derivatives and their preparation
JPH0680054B2 (ja) * 1985-06-19 1994-10-12 吉富製薬株式会社 ピペリジン誘導体
DE3636278A1 (de) 1986-10-24 1988-05-05 Hoechst Ag Herbizide mittel auf der basis von cyclischen (alpha)-iminocarbon-saeureaniliden sowie neue (alpha)-iminocarbonsaeureanilide und verfahren zu ihrer herstellung
IL95994A0 (en) * 1989-11-15 1991-07-18 American Home Prod Carbamate esters and pharmaceutical compositions containing them
JP2864489B2 (ja) * 1991-02-27 1999-03-03 吉富製薬株式会社 喘息治療剤
EP0589985A1 (en) * 1991-06-21 1994-04-06 Boehringer Mannheim Italia S.P.A. 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract
NZ240863A (en) 1991-09-11 1995-04-27 Mcneilab Inc Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof
CA2077252C (en) 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
DE4234295A1 (de) 1992-10-12 1994-04-14 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
ES2191117T3 (es) 1995-10-25 2003-09-01 Degussa Sulfonamidas herbicidas.
AUPO735997A0 (en) * 1997-06-17 1997-07-10 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
EP1009405A4 (en) * 1997-08-28 2001-05-09 Merck & Co Inc PAYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
DE19743435A1 (de) * 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
US6331545B1 (en) * 1998-12-18 2001-12-18 Soo S. Ko Heterocycyclic piperidines as modulators of chemokine receptor activity
PE20010628A1 (es) 1999-10-01 2001-06-18 Takeda Chemical Industries Ltd Compuestos de amina ciclica, su produccion y su uso
US6506751B1 (en) * 1999-11-12 2003-01-14 Millennium Pharmaceuticals, Inc. Thiazolidinone compounds useful as chemokine inhibitors
AR033517A1 (es) * 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
US6964974B2 (en) * 2000-09-08 2005-11-15 Hoffmann-La Roche Inc. 2,3-oxidosqualene-lanosterol cyclase inhibitors
EP1334089A1 (en) * 2000-11-13 2003-08-13 GlaxoSmithKline S.p.A. Quinoline derivatives as nk-3 and nk-2 antagonists
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
WO2002079151A1 (en) 2001-03-29 2002-10-10 Smithkline Beecham P.L.C. 3-substituted indoels or fused pyrroles as antagonists of the chemokine mcp-1 (ccr2b) receptor
WO2003072197A1 (en) 2002-02-27 2003-09-04 Pfizer Products Inc. Acc inhibitors
DK1522314T3 (da) * 2002-06-26 2014-05-26 Ono Pharmaceutical Co Midler for sygdomme forårsaget af vaskulær sammentrækning eller udvidelse
JP2006508948A (ja) * 2002-10-30 2006-03-16 メルク エンド カムパニー インコーポレーテッド ケモカイン受容体活性のヘテロアリールピペリジンモジュレーター
WO2004050024A2 (en) 2002-11-27 2004-06-17 Incyte Corporation 3-aminopyrrolidine derivatives as modulators of chemokine receptors
US20040147502A1 (en) * 2002-12-17 2004-07-29 Bisacchi Gregory S. Beta lactam compounds and their use as inhibitors of tryptase
GB0308801D0 (en) 2003-04-16 2003-05-21 Celltech R&D Ltd Chemical compounds
KR100799534B1 (ko) * 2004-02-27 2008-01-31 에자이 알앤드디 매니지먼트 가부시키가이샤 신규 피리딘 유도체 및 피리미딘 유도체(1)
FR2872813B1 (fr) * 2004-07-09 2007-01-19 Sanofi Synthelabo Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique
DK1776366T3 (da) * 2004-08-09 2009-02-16 Medigene Ltd Immunomodulerende oxopyrazolocinnoliner som CD80-inhibitorer
GB0419072D0 (en) * 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
CA2589748C (en) * 2004-12-24 2013-08-13 Astrazeneca Ab Heterocyclic compounds as ccr2b antagonists
GB0525957D0 (en) * 2005-12-21 2006-02-01 Astrazeneca Ab Methods
US20100152197A1 (en) * 2008-12-15 2010-06-17 Astrazeneca Ab (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives

Similar Documents

Publication Publication Date Title
US7557127B2 (en) HDAC inhibitor
US8394962B2 (en) Method for the preparation of dabigatran and its intermediates
ES2287782T3 (es) Derivados de n-(heteroaril(piperidin-2-il)metil)benzamida, su preparacion y su aplicacion en terapeutica.
AU2001281972B2 (en) Piperidine coumpounds for use as CCR-3 inhibitors
DE69634806T2 (de) Substituierte heterocyclische Verbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
EP0707006B1 (de) Aroyl-piperidin-Derivate
ES2335519T3 (es) Derivados del pirrol que tienen actividad antagonista del receptor crth2.
HU211968A9 (en) Heterocyclic amines useful in the therapy of asthma and inflammation of the respiratory tract
AU2005272389B2 (en) Novel cyclic aminobenzoic acid derivative
CA2724998A1 (en) Nicotinamide derivatives
JP2009167215A (ja) 新規ジアリールアルケン誘導体及び新規ジアリールアルカン誘導体
DK2059503T3 (en) Aminopyrazole derivatives, processes for their preparation, and compositions containing these derivatives for the prevention or treatment of ischemic diseases
RS50542B (sr) Derivati alkilpiperazin- i alkilhomopiperazin-karboksilata, postupci za njihovo dobijanje i njihova primena kao inhibitora enzima faah
BE1009571A3 (fr) Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant.
KR20100065377A (ko) 2- 및 3-위치에서 치환된 5,6-디아릴 피리딘, 그의 제법, 및 그의 치료학적 용도
JP2008525359A (ja) M3アンタゴニストとしての第4級アンモニウム塩類
CA2530310C (en) Substituted diketopiperazines and their use as oxytocin antagonists
CA2912735A1 (en) Novel tetrazolone derivatives
WO2005035528A2 (en) Triazole derivatives as antibacterial agents
CN101208302A (zh) 作为天冬氨酸蛋白酶ii抑制剂的新型4-胺基哌啶衍生物
JP6096808B2 (ja) 新規なアゼチジン誘導体
EP1324984A1 (de) Butenolid- und pentenolidderivate als kinase inhibitoren
KR102325422B1 (ko) 엔테로펩티다아제 억제 활성을 나타내는 신규 화합물
HK1041881A1 (en) Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them